OVERVIEW

Finding Energy in the Path Forward: A New Lead in Chronic Fatigue Treatment - Frankly Speaking Ep 440 is organized by Pri-Med.

Release Date: 07/07/2025
Expiration Date: 07/07/2027

Description:
Explore current and emerging treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating condition with no known cause or cure. Learn how oxaloacetate may offer new hope for patients struggling with ME/CFS, and gain practical guidance to support informed, evidence-based conversations with your patients.

Learning Objectives:

  • Explain the standard treatment for chronic fatigue syndrome (CFS)
  • Review the latest data on the use of oxaloacetate for treating fatigue associated with myalgic encephalomyelitis (ME)/CFS

Topics:

  • Psychiatry & Behavioral Health
  • Rheumatology
Credits

Accreditation Statement:
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement:
Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 CME
  • TARGET AUDIENCE

    rheumatologyPsychiatryBehavioral Health Nurses

    SPECIALITIES

    PsychiatryBehavioral HealthRheumatology

    RELATED ONLINE COURSES

    Webcast

    Rheumatology
    7 CE Hours
    More actions
    US$99.95

    Webcast

    Emergency Medicine
    More actions
    US$200